Sentinel Trust Co. LBA cut its holdings in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 12.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,191 shares of the company’s stock after selling 1,999 shares during the period. Sentinel Trust Co. LBA’s holdings in BlackRock Health Sciences Term Trust were worth $204,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in BMEZ. Jane Street Group LLC bought a new stake in shares of BlackRock Health Sciences Term Trust during the third quarter worth $357,000. Kingswood Wealth Advisors LLC acquired a new position in BlackRock Health Sciences Term Trust in the 4th quarter worth $420,000. Oppenheimer & Co. Inc. increased its holdings in BlackRock Health Sciences Term Trust by 0.6% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 204,354 shares of the company’s stock worth $3,237,000 after purchasing an additional 1,153 shares in the last quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new stake in shares of BlackRock Health Sciences Term Trust in the 4th quarter valued at about $471,000. Finally, Wolverine Asset Management LLC raised its stake in shares of BlackRock Health Sciences Term Trust by 496.1% in the 4th quarter. Wolverine Asset Management LLC now owns 187,617 shares of the company’s stock valued at $2,702,000 after purchasing an additional 156,141 shares during the period.
BlackRock Health Sciences Term Trust Stock Down 0.4 %
BMEZ stock opened at $15.68 on Friday. BlackRock Health Sciences Term Trust has a fifty-two week low of $14.27 and a fifty-two week high of $16.75. The business has a 50-day moving average of $15.64 and a 200-day moving average of $15.68.
BlackRock Health Sciences Term Trust Announces Dividend
BlackRock Health Sciences Term Trust Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
See Also
- Five stocks we like better than BlackRock Health Sciences Term Trust
- When to Sell a Stock for Profit or Loss
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- What Does a Stock Split Mean?
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- Quiet Period Expirations Explained
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.